Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 1, 2004
- PRESS SEMINAR
November 1, 2004
- Health Science Technology Transfer Center Starts Full Activities
November 1, 2004
- Fuji Biomedix, SCAS Tie Up in Drug Development Support Business
November 1, 2004
- NEW PRODUCTS
November 1, 2004
- Business Forecast
November 1, 2004
- BUSINESS NEWS IN BRIEF
November 1, 2004
- 1st 3Qtrs Business Results
November 1, 2004
- NBI Obtains Import Approval of Spiriva
November 1, 2004
- Semi-annual Business Results
November 1, 2004
- Pegintron Receives Import Approval
November 1, 2004
- Sandostatin Approved for GI Symptoms due to GI Tract Obstruction
November 1, 2004
- WEBSITE NWES
October 25, 2004
- EFPIA Survey Finds Problems in Clinical Trial Environment
October 25, 2004
- Korosho to Consider 8-Year Data Protection Period in Earnest
October 25, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
October 25, 2004
- Production Value of Drugs Rose 0.7% in 2003
October 25, 2004
- OTC NEWS IN BRIEF
October 25, 2004
- Notification Explains Requirements for Interviews on Review Progress
October 25, 2004
- MONITOR
October 25, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…